MAYNE PHARMA LIMITED – Trademark Portfolio

Entity Type: 11

MAYNE PHARMA LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ONCO-TAIN. The owner is based in MELBOURNE.

LEVEL 21, 390 ST. KILDA ROAD

MELBOURNE 3004 , AU

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONCO-TAIN
ONCO-TAIN
Registered 2003
DBL
DBL
Cancelled 2000

Trademark Classifications

MAYNE PHARMA LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does MAYNE PHARMA LIMITED have?

MAYNE PHARMA LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does MAYNE PHARMA LIMITED file in?

MAYNE PHARMA LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MAYNE PHARMA LIMITED's most well-known trademarks?

MAYNE PHARMA LIMITED's registered trademark portfolio includes well-known marks such as ONCO-TAIN. These are among 1 currently registered trademark in the portfolio.

What is MAYNE PHARMA LIMITED's trademark registration success rate?

MAYNE PHARMA LIMITED has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.